Evaluating Process of Change in Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for Depression
Researching and Improving Psychotherapy Techniques in Interventions for DEpression (RIPTIDE)
1 other identifier
interventional
100
1 country
1
Brief Summary
This study will compare two psychological treatments for major depressive disorder (MDD): cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT). Both treatments are well-studied and supported by evidence as effective options for people experiencing depression. These treatments will be delivered in an online group format via Zoom. The study will enroll up to 100 participants with depression. Half of the participants will receive online group CBT and half will receive online group ACT. There will be up to 10 members in each group. For both conditions, treatment will be provided over 8 weeks, with a 6-month follow-up period. Enrollment will be ongoing and groups will occur simultaneously. Potential participants are asked to complete an initial screening and an intake evaluation to determine eligibility. They will then receive 8-weeks of treatment. Participants will complete self-report questionnaires throughout their time in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Jan 2024
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2024
CompletedFirst Submitted
Initial submission to the registry
January 24, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2026
CompletedDecember 18, 2025
March 1, 2025
1.8 years
January 24, 2024
December 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Chain of Change Treatment Diary (ChaCha-TD)
The ChaCha-TD designed by our research group assesses participants' affect, symptoms, quality of life, significant life events, skills use, and mechanisms of treatment change in daily life.
Three days per week during the eight-week course of treatment at 8 p.m. on preselected days.
Secondary Outcomes (15)
Generalized Anxiety Disorder Questionnaire (GAD-7)
Intake, Post-treatment (8 weeks)
WHO Quality of Life-Brief (WHOQOL-BREF)
Intake, Post-treatment (8-weeks), and follow-up (6-months)
Positive and Negative Affect Schedule (PANAS)
Intake, Post-treatment (8-weeks), and follow-up (6-months)
Patient Health Questionnaire (PHQ-9)
Intake, Post-treatment (8-weeks), and follow-up (6-months)
Discrimination-Related Vigilance Scale (DRVS)
Intake, Post-treatment (8-weeks)
- +10 more secondary outcomes
Study Arms (2)
Cognitive Behavioral Therapy
ACTIVE COMPARATOROver 8 sessions, clients learn techniques to challenge and change maladaptive thought and behavioral patterns
Acceptance and Commitment Therapy
ACTIVE COMPARATOROver 8 sessions, clients learn techniques to accept their negative internal experiences and commit to action in line with their values
Interventions
Sessions will focus on skills such as behavioral activation, mood tracking, identifying and reframing automatic thoughts, assertion training and smart goals.
Sessions will focus on skills such as mindfulness, acceptance and willingness training, values clarification, committed action, defusion, and self-as-context.
Eligibility Criteria
You may qualify if:
- diagnosis of major depressive disorder (MDD) according to DSM-V criteria (APA, 2013)
- years of age or older
- access to a private location with a stable internet connection and a working video camera
- lives in California
- able to understand and speak English
- able and willing to give informed consent
You may not qualify if:
- current diagnosis other than MDD if it constitutes the predominant aspect of the clinical presentation and if it requires treatment other than that being offered
- clear indication of secondary gain (e.g., court ordered treatment)
- current suicide risk or significant intentional self-harm in the last six months sufficient to preclude treatment on an outpatient basis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Southern California
Los Angeles, California, 90007, United States
Related Publications (1)
Dao A, Bernstein RA, Ramos FN, Beasley B, Ezawa ID. Unpacking the chain of change in group CBT and ACT for depression: A protocol for a randomized clinical trial. Contemp Clin Trials. 2025 Jun;153:107907. doi: 10.1016/j.cct.2025.107907. Epub 2025 Apr 2.
PMID: 40185199DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iony D Ezawa, PhD
University of Southern California
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 24, 2024
First Posted
February 7, 2024
Study Start
January 15, 2024
Primary Completion
November 3, 2025
Study Completion
April 27, 2026
Last Updated
December 18, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share